BRIEF published on 06/18/2025 at 07:05, 1 year ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
BRIEF published on 06/18/2025 at 07:05, 1 year ago PHAXIAM Therapeutics suspend la cotation de son titre Euronext Paris Suspension Cotation Traitements Innovants PHAXIAM Radiation Titres
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend la cotation de son titre sur Euronext Paris en raison d'un prochain retrait de la cote, sans remboursement aux actionnaires Euronext Paris Cotation Suspension Retrait PHAXIAM Therapeutics
BRIEF published on 06/05/2025 at 07:05, 1 year ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
BRIEF published on 06/05/2025 at 07:05, 1 year ago PHAXIAM Therapeutics menacée de liquidation suite au report de l'audience Liquidation Judiciaire Produits Biopharmaceutiques PHAXIAM Thérapeutique Audience Au Tribunal Radiation D'Euronext
PRESS RELEASE published on 06/05/2025 at 07:00, 1 year ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year 3 months ago PHAXIAM Therapeutics cherche repreneur en redressement judiciaire Euronext Paris Redressement Judiciaire PHAXIAM Therapeutics Recherche Repreneur Prolongation Procédure
BRIEF published on 03/14/2025 at 17:50, 1 year 3 months ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 3 months ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
Published on 06/24/2026 at 03:15, 34 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 3 hours 49 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 4 hours 4 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 4 hours 29 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 4 hours 34 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 02:05, 1 hour 44 minutes ago FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO
Published on 06/23/2026 at 22:20, 5 hours 29 minutes ago Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 7 hours 34 minutes ago EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:30, 9 hours 19 minutes ago IEVA GROUP: COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ANNUELLE DU 23 JUIN 2026
Published on 06/23/2026 at 19:47, 8 hours 1 minute ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 8 hours 1 minute ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 8 hours 39 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 8 hours 39 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 9 hours 16 minutes ago Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix
